US 11505620
Methods of detecting plasma kallikrein
granted A61KA61K2039/505A61K49/0004
Quick answer
US patent 11505620 (Methods of detecting plasma kallikrein) held by Takeda Pharmaceutical Company Limited expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K49/0004, A61P, A61P1/00